GGrantIndex
Sort

50,496 grants matching lung cancer

Enhancing Native American Participation in RT Trials

$896,038
Rapid City Regional Hospital · U56 · FY2003 · CA

Factors for Epigenetic Silencing of Lung Cancer Genes

$895,885
Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · U01 · FY2008 · CA

(2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership

$895,790
Olorunseun O Ogunwobi · Hunter College · U54 · FY2020 · CA

NYU Lung Cancer Biomarker Center

$895,726
William N Rom · New York University School Of Medicine · U01 · FY2012 · CA

DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs

$895,684
Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)

$895,649
Sten H Vermund · Vanderbilt University · R25 · FY2015 · TW

Genes contributing for nicotine dependence in humans

$895,389
Kari Stefansson · Decode Genetics, Ehf · R01 · FY2013 · DA

Leadership, Planning and Evaluation

$895,353
Caryn Lerman · University Of Southern California · P30 · FY2024 · CA

Pathomic Predictors of Prostate Cancer Progression

$895,176
Parag Kumar Mallick · Stanford University · R01 · FY2023 · CA

Symptoms Clusters in Oncology Patients Receiving Chemotherapy

$895,046
Christine A. Miaskowski · University Of California, San Francisco · R01 · FY2014 · CA

Lung Cancer Screening to Improve Equity in Tribal Communities in Oklahoma (Lung-Screen-Tribal OK)

$894,886
Zsolt J Nagykaldi · University Of Oklahoma Hlth Sciences Ctr · U19 · FY2024 · MD

Interactive Digital Media to Support Children's Learning about Tobacco and the Human Body: "Dusty the Dragon"

$894,755
Don Rawitsch · Moai Technologies, Llc · R44 · FY2018 · GM

SUPPORT SERVICES FOR THE PLCO ETIOLOGIC & EARLY MARKER STUDIES(PLCO EEMS)

$894,589
Tom Riley · Information Management Services, Inc. · N02 · FY2017 · CA

Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer

$894,497
Gloria M. Petersen · Mayo Clinic Rochester · U01 · FY2020 · CA

Multi-Cancer Early Detection and Screening (MED SCREEN) Study

$894,340
Jeffrey Kuang Zou Lee · Kaiser Foundation Research Institute · UG1 · FY2025 · CA

Epidemiology of putative genuine genetic variant: The Women's Health Intiative

$893,905
Charles L Kooperberg · Fred Hutchinson Cancer Research Center · U01 · FY2012 · HG

NRF Transcription Factors in Environmental Stress and Disease Intervention

$893,829
Donna D Zhang · University Of Arizona · R35 · FY2020 · ES

Development of CA-IL-12 for Triple Negative Breast Cancer

$893,673
Edward J Filardo · Cytonus Therapeutics, Inc. · R44 · FY2024 · CA

Improving Strategies for Cancer Reduction through Early-detection and ENgagement (I-SCREEN)

$893,587
Linda S Cook · University Of Colorado Denver · UG1 · FY2025 · CA

THE GENETICS OF VULNERABILITY TO NICOTINE ADDICTIONS

$893,543
Pamela Ann Madden · Washington University · R01 · FY2009 · DA

Functional Analysis of Oncogenic Networks in Primary Organoids

$893,517
Calvin J Kuo · Stanford University · U01 · FY2014 · CA

Biomarkers and mechanisms in cancer associated thrombosis

$893,486
Jeffrey Zwicker · Beth Israel Deaconess Medical Center · U01 · FY2018 · HL

Computer Integrated Systems for Microscopy&Manipulation

$893,053
Richard Superfine · Univ Of North Carolina Chapel Hill · P41 · FY2009 · EB

Monitoring Response to Targeted Therapy in Non-Small Cell Lung Cancer Using 18F..

$892,981
Sanjiv S Gambhir · Stanford University · P50 · FY2010 · CA

MMPA: A Novel Multiplexing Methylation Analysis Technology

$892,755
Baochuan Guo · Glc Biotechnology, Inc. · R44 · FY2009 · CA